Publication:
Risk Factors for Short-Term Lung Cancer Survival.

dc.contributor.authorCaballero-Vázquez, Alberto
dc.contributor.authorRomero-Béjar, José Luis
dc.contributor.authorAlbendín-García, Luis
dc.contributor.authorSuleiman-Martos, Nora
dc.contributor.authorGómez-Urquiza, José Luis
dc.contributor.authorCañadas, Gustavo Raúl
dc.contributor.authorCañadas-De la Fuente, Guillermo Arturo
dc.date.accessioned2023-02-09T10:41:00Z
dc.date.available2023-02-09T10:41:00Z
dc.date.issued2021-02-01
dc.description.abstractLung cancer is typically diagnosed in an advanced phase of its natural history. Explanatory models based on epidemiological and clinical variables provide an approximation of patient survival less than one year using information extracted from the case history only, whereas models involving therapeutic variables must confirm that any treatment applied is worse than surgery in survival terms. Models for classifying less than one year survival for patients diagnosed with lung cancer which are able to identify risk factors and quantify their effect for prognosis are analyzed. Two stepwise binary logistic regression models, based on a retrospective study of 521 cases of patients diagnosed with lung cancer in the Interventional Pneumology Unit at the Hospital "Virgen de las Nieves", Granada, Spain. The first model included variables age, history of pulmonary neoplasm, tumor location, dyspnea, dysphonia, and chest pain. The independent risk factors age greater than 70 years, a peripheral location, dyspnea and dysphonia were significant. For the second model, treatments were also significant. Age, history of pulmonary neoplasm, tumor location, dyspnea, dysphonia, and chest pain are predictors for survival in patients diagnosed with lung cancer at the time of diagnosis. The treatment applied is significant for classifying less than one year survival time which confirms that any treatment is markedly inferior to surgery in terms of survival. This allows to consider applications of more or less aggressive treatments, anticipation of palliative cares or comfort measures, inclusion in clinical trials, etc.
dc.identifier.doi10.3390/jcm10030519
dc.identifier.issn2077-0383
dc.identifier.pmcPMC7867142
dc.identifier.pmid33535673
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867142/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2077-0383/10/3/519/pdf?version=1612320086
dc.identifier.urihttp://hdl.handle.net/10668/17095
dc.issue.number3
dc.journal.titleJournal of clinical medicine
dc.journal.titleabbreviationJ Clin Med
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectepidemiological risk factors
dc.subjectlogistic regression
dc.subjectlung cancer
dc.subjectshort-term survival
dc.subjecttreatments
dc.titleRisk Factors for Short-Term Lung Cancer Survival.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number10
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7867142.pdf
Size:
266.52 KB
Format:
Adobe Portable Document Format